Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A de Jonge

Showing results (171-180 of 286) with videos related to

Pageof 29
Sort By:
Birth (Berkeley, Calif.)|December 19, 2013
The use of episiotomy in a low-risk population in the Netherlands: a secondary analysisA E Seijmonsbergen-Schermers, C C Geerts, M Prins, et al.
Cancer Chemotherapy and Pharmacology|March 18, 2006
A pharmacokinetic interaction study of docetaxel and cisplatin plus or minus 5-fluorouracil in the treatment of patients with recurrent or metastatic solid tumorsA Felici, W J Loos, J Verweij, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|April 7, 2017
Pitfalls in the use of register-based data for comparing adverse maternal and perinatal outcomes in different birth settingsA de Jonge, Mgaj Wouters, J Klinkert, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 16, 2007
Increased blood loss in upright birthing positions originates from perineal damageA de Jonge, M Th van Diem, P L H Scheepers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 27, 2007
A multicentre phase I and pharmacokinetic study of BN80915 (diflomotecan) administered daily as a 20-min intravenous infusion for 5 days every 3 weeks to patients with advanced solid tumoursL Scott, O Soepenberg, J Verweij, et al.
Journal of Veterinary Pharmacology and Therapeutics|December 1, 1989
Lack of oxidative pathways in the metabolism of sulphisomidine by the turtle Pseudemys scripta elegansT B Vree, J B Vree, P A De Jonge, et al.
European Journal of Cancer (Oxford, England : 1990)|March 29, 2011
Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumoursM J A de Jonge, H Dumez, J J E M Kitzen, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|May 19, 2023
Predictive value of fetal growth trajectory from 20 weeks of gestation onwards for severe adverse perinatal outcome in low-risk population: secondary analysis of IRIS studyH D Kamphof, M van Roekel, J Henrichs, et al.
Investigational New Drugs|October 12, 2012
Phase I and pharmacokinetic study of pazopanib and lapatinib combination therapy in patients with advanced solid tumorsMaja J A de Jonge, Paul Hamberg, Jaap Verweij, et al.
Antimicrobial Resistance and Infection Control|December 18, 2022
Guidance of empirical antimicrobial therapy by surveillance cultures in high-risk neutropenic patients: a retrospective cohort studyJara R de la Court, Jarom Heijmans, Jennifer Huynh, et al.
Pageof 29

Showing results (171-180 of 286) with videos related to

Sort By:
Pageof 29
Birth (Berkeley, Calif.)|December 19, 2013
The use of episiotomy in a low-risk population in the Netherlands: a secondary analysisA E Seijmonsbergen-Schermers, C C Geerts, M Prins, et al.
Cancer Chemotherapy and Pharmacology|March 18, 2006
A pharmacokinetic interaction study of docetaxel and cisplatin plus or minus 5-fluorouracil in the treatment of patients with recurrent or metastatic solid tumorsA Felici, W J Loos, J Verweij, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|April 7, 2017
Pitfalls in the use of register-based data for comparing adverse maternal and perinatal outcomes in different birth settingsA de Jonge, Mgaj Wouters, J Klinkert, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 16, 2007
Increased blood loss in upright birthing positions originates from perineal damageA de Jonge, M Th van Diem, P L H Scheepers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 27, 2007
A multicentre phase I and pharmacokinetic study of BN80915 (diflomotecan) administered daily as a 20-min intravenous infusion for 5 days every 3 weeks to patients with advanced solid tumoursL Scott, O Soepenberg, J Verweij, et al.
Journal of Veterinary Pharmacology and Therapeutics|December 1, 1989
Lack of oxidative pathways in the metabolism of sulphisomidine by the turtle Pseudemys scripta elegansT B Vree, J B Vree, P A De Jonge, et al.
European Journal of Cancer (Oxford, England : 1990)|March 29, 2011
Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumoursM J A de Jonge, H Dumez, J J E M Kitzen, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|May 19, 2023
Predictive value of fetal growth trajectory from 20 weeks of gestation onwards for severe adverse perinatal outcome in low-risk population: secondary analysis of IRIS studyH D Kamphof, M van Roekel, J Henrichs, et al.
Investigational New Drugs|October 12, 2012
Phase I and pharmacokinetic study of pazopanib and lapatinib combination therapy in patients with advanced solid tumorsMaja J A de Jonge, Paul Hamberg, Jaap Verweij, et al.
Antimicrobial Resistance and Infection Control|December 18, 2022
Guidance of empirical antimicrobial therapy by surveillance cultures in high-risk neutropenic patients: a retrospective cohort studyJara R de la Court, Jarom Heijmans, Jennifer Huynh, et al.
Pageof 29